Clinical Trials Directory

Trials / Conditions / Ocular Pain

Ocular Pain

11 registered clinical trials studyying Ocular Pain — 1 currently recruiting.

StatusTrialSponsorPhase
Active Not RecruitingA Study to Assess Safety, Tolerability, and Pharmacokinetics of Ascending Concentrations of Topical Ocular BL1
NCT06978244
Bausch & Lomb IncorporatedPhase 1
Not Yet RecruitingValidation of Ocular Pain Questionnaire: Single-center, Prospective Observational Study
NCT06656260
IRCCS Ospedale San Raffaele—
CompletedEvaluate the TetraLens, a Tetracaine Releasing Therapeutic Bandage Contact Lens in Patients Undergoing PRK Pro
NCT06085352
Vance Thompson VisionEARLY_Phase 1
CompletedAssessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery
NCT05626478
Nicole Fram M.D.Phase 4
CompletedA Retrospective Review of DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract Surgery
NCT04975971
Nicole Fram M.D.—
CompletedAssessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery
NCT04521140
Nicole Fram M.D.Phase 4
CompletedEfficacy and Safety of PRO-155 on Inflammation of the Conjunctival Surface in Subjects With Grade I-III Pteryg
NCT03521791
Laboratorios Sophia S.A de C.V.Phase 4
CompletedDose-finding Study to Assess the Safety and Effect of SYL1001 in Patients With Ocular Pain
NCT02455999
Sylentis, S.A.Phase 2
CompletedRTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery -
NCT02128113
BiogenPhase 2
CompletedPilot Study to Evaluate SYL1001 Safety and Effect in Patients With Ocular Pain
NCT01776658
Sylentis, S.A.Phase 1 / Phase 2
CompletedStudy to Evaluate the Ocular Tolerance of SYL1001 in Healthy Volunteers
NCT01438281
Sylentis, S.A.Phase 1